LIOTHYRONINE SODIUM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Liothyronine Sodium, and when can generic versions of Liothyronine Sodium launch?
Liothyronine Sodium is a drug marketed by Xgen Pharms, Carnegie, Dr Reddys Labs Sa, Mylan, Sigmapharm Labs Llc, Sun Pharm, Teva Pharms Usa, Watson Labs, and Zydus. and is included in ten NDAs.
The generic ingredient in LIOTHYRONINE SODIUM is liothyronine sodium. There are four drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the liothyronine sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Liothyronine Sodium
A generic version of LIOTHYRONINE SODIUM was approved as liothyronine sodium by XGEN PHARMS on August 17th, 2005.
Summary for LIOTHYRONINE SODIUM
US Patents: | 0 |
Applicants: | 9 |
NDAs: | 10 |
Finished Product Suppliers / Packagers: | 18 |
Raw Ingredient (Bulk) Api Vendors: | 76 |
Clinical Trials: | 15 |
Patent Applications: | 1,189 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in LIOTHYRONINE SODIUM? | LIOTHYRONINE SODIUM excipients list |
DailyMed Link: | LIOTHYRONINE SODIUM at DailyMed |
Recent Clinical Trials for LIOTHYRONINE SODIUM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Minnesota | Phase 1/Phase 2 |
University of Minnesota - Clinical and Translational Science Institute | Phase 1/Phase 2 |
Aultman Health Foundation | Phase 2 |
Pharmacology for LIOTHYRONINE SODIUM
Drug Class | l-Triiodothyronine |
Anatomical Therapeutic Chemical (ATC) Classes for LIOTHYRONINE SODIUM
US Patents and Regulatory Information for LIOTHYRONINE SODIUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Xgen Pharms | LIOTHYRONINE SODIUM | liothyronine sodium | INJECTABLE;INJECTION | 076923-001 | Aug 17, 2005 | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Teva Pharms Usa | LIOTHYRONINE SODIUM | liothyronine sodium | TABLET;ORAL | 211510-002 | Oct 26, 2018 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Zydus | LIOTHYRONINE SODIUM | liothyronine sodium | TABLET;ORAL | 214803-003 | Jan 22, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |